Abcellera Biologics Stock Options
| ABCL Stock | USD 2.97 0.03 1.02% |
Abcellera Biologics' latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.32 with a put-to-call open interest ratio of 0.13 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 26.0, with calls trading at the volume of 88.0. This yields a 0.3 put-to-call volume ratio.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Abcellera Biologics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Abcellera Biologics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Abcellera Biologics' option, there is no secondary market available for investors to trade.
Abcellera Biologics Maximum Pain Price Across 2025-04-17 Option Contracts
Abcellera Biologics' max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Abcellera Biologics
Analyzing Abcellera Biologics' in-the-money options over time can help investors to take a profitable long position in Abcellera Biologics regardless of its overall volatility. This is especially true when Abcellera Biologics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Abcellera Biologics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Abcellera Biologics' stock while costing only a fraction of its price.
Abcellera Biologics In The Money Call Balance
When Abcellera Biologics' strike price is surpassing the current stock price, the option contract against Abcellera Biologics stock is said to be in the money. When it comes to buying Abcellera Biologics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Abcellera Biologics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Abcellera Current Options Market Mood
Abcellera Biologics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Abcellera Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Abcellera Biologics' options investors are not very successful. Abcellera Biologics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Abcellera contract
Base on the Rule 16, the options market is currently suggesting that Abcellera Biologics will have an average daily up or down price movement of about 0.0825% per day over the life of the 2025-04-17 option contract. With Abcellera Biologics trading at USD 2.97, that is roughly USD 0.00245. If you think that the market is fully incorporating Abcellera Biologics' daily price movement you should consider buying Abcellera Biologics options at the current volatility level of 1.32%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Abcellera |
Purchasing Abcellera Biologics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Abcellera calls. Remember, the seller must deliver Abcellera Biologics stock to the call owner when a call is exercised.
Abcellera Biologics Option Chain
When Abcellera Biologics' strike price is surpassing the current stock price, the option contract against Abcellera Biologics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Abcellera Biologics' option chain is a display of a range of information that helps investors for ways to trade options on Abcellera. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Abcellera. It also shows strike prices and maturity days for a Abcellera Biologics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ABCL250417C00001000 | 34 | 1.0 | 1.65 - 2.1 | 1.9 | In |
Call | ABCL250417C00002000 | 563 | 2.0 | 0.25 - 2.0 | 1.05 | In |
Call | ABCL250417C00003000 | 1528 | 3.0 | 0.4 - 0.5 | 0.47 | Out |
Call | ABCL250417C00004000 | 6594 | 4.0 | 0.2 - 0.3 | 0.2 | Out |
Call | ABCL250417C00005000 | 549 | 5.0 | 0.0 - 0.2 | 0.14 | Out |
Call | ABCL250417C00006000 | 361 | 6.0 | 0.0 - 0.15 | 0.15 | Out |
Put | ABCL250417P00001000 | 0 | 1.0 | 0.0 - 2.65 | 2.65 | |
Put | ABCL250417P00002000 | 260 | 2.0 | 0.0 - 4.9 | 0.18 | Out |
Put | ABCL250417P00003000 | 443 | 3.0 | 0.4 - 0.7 | 0.45 | In |
Put | ABCL250417P00004000 | 566 | 4.0 | 0.5 - 4.9 | 1.0 | In |
Put | ABCL250417P00005000 | 29 | 5.0 | 1.8 - 2.45 | 2.21 | In |
Put | ABCL250417P00006000 | 1 | 6.0 | 2.6 - 5.5 | 2.8 | In |
Abcellera Biologics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Abcellera Biologics Market Cap Over Time
Market Cap |
| Timeline |
Abcellera Total Stockholder Equity
Total Stockholder Equity |
|
Abcellera Biologics Corporate Management
| Andy Clark | Head Assurance | Profile | |
| Veronique Lecault | COO Director | Profile | |
| Bo Barnhart | Scientific Director | Profile | |
| Andrew MBA | Chief Officer | Profile | |
| EdD CEC | Senior Development | Profile | |
| Paul Colussi | Site Technologies | Profile | |
| JD Esq | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.